Transcription factors in the pathogenesis of diabetic nephropathy.
about
Diabetic neuropathic pain: Physiopathology and treatmentGeldanamycin derivative ameliorates high fat diet-induced renal failure in diabetesC3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathwayPathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.Diabetic nephropathy - complications and treatment.Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigsActivation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury.Epigenetic mechanisms in diabetic complications and metabolic memory.Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses.Role of the USF1 transcription factor in diabetic kidney disease.Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in PodocytesEpigenetics in diabetic kidney disease.Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.Signaling mechanisms in the regulation of renal matrix metabolism in diabetes.Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin.Recent developments in epigenetics of acute and chronic kidney diseases.RAGE and TGF-β1 Cross-Talk Regulate Extracellular Matrix Turnover and Cytokine Synthesis in AGEs Exposed Fibroblast CellsBioinformatic Evaluation of Transcriptional Regulation of WNT Pathway Genes with reference to Diabetic NephropathyEpigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic NephropathyProtective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage.Oxidative stress in diabetic nephropathy.Epigenetic modifications in the pathogenesis of diabetic nephropathyAdipokines protecting CKD.Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney.Novel aldose reductase inhibitors: a patent survey (2006--present).Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy.Diabetic nephropathy and inflammation.Histone lysine methylation in diabetic nephropathy.Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress.Is there a place for inhibition of transforming growth factor-β and the polyol pathway in therapy for diabetic retinopathy?High glucose induces reactive oxygen species-dependent matrix metalloproteinase-9 expression and cell migration in brain astrocytes.4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy.Increased CD4(+)CXCR5(+)T follicular helper cells in diabetic nephropathy.Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice.Toll-like receptor 2 agonist exacerbates renal injury in diabetic mice.TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.Sphingosine kinase 1 mediates diabetic renal fibrosis via NF-κB signaling pathway: involvement of CK2α.
P2860
Q27004604-B98FF3A4-023B-454B-8C56-EBC01CADD5AEQ27307854-72C7EF43-97D1-4CF8-B4A1-7EDCB01FD6E8Q28545168-A976A4FF-249B-4EE7-A6EF-4C08BD63FEF0Q33917811-EC33C33F-AAC1-438F-BEBD-8E524CB242AFQ34387952-6F3B0027-9473-46EF-8179-D4D22819A938Q34551722-FBBF6BB7-8057-4B12-BABF-3AAA4F41098DQ34737936-F6D23314-216D-4D33-9A9B-63FDAB5BB436Q35071700-D9B49629-8F46-4D71-BFA3-9EE18034275CQ35144977-9524ECD8-A2D0-47C8-B9E7-09041FE035D5Q35159588-976852DD-59F4-4755-AA79-EF28BDDAF323Q35583071-4F1E6A17-D8B6-44EC-9957-E41FE1AD86B3Q35647853-E64EC728-5F71-4CF1-8983-491E9611B944Q35664105-323F5CAB-A914-4E62-9C58-58A176B6D4CAQ35791976-D23ED3A9-B40C-4C49-AD5A-0AF1E8DE74A8Q35857721-A37CDADD-CE3E-4967-A319-6DC9F8DA6E32Q35909055-FA5865C2-4F37-4DE1-877C-6722703012A5Q35970395-CD385DC2-1884-425A-AED6-AFF0FB9830E1Q36366892-2A7A86E5-3F1B-448B-926F-1EA8CD62579CQ36656799-C0D3912F-6EFA-44A5-8819-11CC01D9978DQ36853627-D13EF31F-9019-48F8-94F4-67868CE0E618Q37003803-6B7DF7D9-315C-4159-B420-1D0AB6E4DE3BQ37158080-694CAFB7-EA83-4B80-AA2B-A0CAB3373C5DQ37270838-2D514CE3-98FB-464E-A960-97A8230EE2A5Q37575350-3CE99EA6-1125-432E-8642-F9E65D773A19Q38045440-31E4425B-6B96-44B2-B967-9A55BA5C5959Q38217417-D8D3165A-2483-4A93-9D10-7250CBAB6F25Q38220820-50D810E0-95B8-416B-913F-593B9648C3A7Q38248614-925E2541-182F-4F53-9559-798DD4CE0F16Q38663562-D42DD2BF-D26B-4ACF-ABB9-D6AFB7261186Q38831906-56616275-B7F2-4ACA-A47B-75FAC84C4EC8Q39144504-3F097A37-2BA8-4F5E-B1F2-811DD6F9054AQ39160411-A0B31A2B-701F-4A3F-957E-FB350E8155CCQ39176197-164903B1-911D-44A3-A34C-579DB3E94F35Q39293346-A97B66C7-F82F-42EA-BB95-3BE94AEF57F1Q40593574-57FF1A03-C6C9-4768-8B11-833CA5FB8DD5Q41939992-C845A6D3-1BC4-4382-8BC5-CC08D72A9A7DQ42316686-441F4FA0-5C8B-49A7-87F0-7635B7D9BC30Q42365354-FB38D7BF-F942-486B-B7DA-B39A55D8B1B9Q42970293-011836AE-1A50-4550-B472-E4F4791C70CCQ46377053-29CD2456-7ED4-4CD4-9340-728A4AE707A0
P2860
Transcription factors in the pathogenesis of diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transcription factors in the pathogenesis of diabetic nephropathy.
@en
Transcription factors in the pathogenesis of diabetic nephropathy.
@nl
type
label
Transcription factors in the pathogenesis of diabetic nephropathy.
@en
Transcription factors in the pathogenesis of diabetic nephropathy.
@nl
prefLabel
Transcription factors in the pathogenesis of diabetic nephropathy.
@en
Transcription factors in the pathogenesis of diabetic nephropathy.
@nl
P2860
P1476
Transcription factors in the pathogenesis of diabetic nephropathy.
@en
P2093
Amber Paratore Sanchez
Kumar Sharma
P2860
P356
10.1017/S1462399409001057
P577
2009-04-28T00:00:00Z